Insider Selling: Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Sells 2,540 Shares of Stock

Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz sold 2,540 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $58.92, for a total value of $149,656.80. Following the completion of the sale, the senior vice president now owns 15,934 shares of the company’s stock, valued at $938,831.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Prestige Consumer Healthcare Stock Down 1.6 %

Shares of NYSE PBH opened at $57.88 on Monday. The company has a current ratio of 2.66, a quick ratio of 1.51 and a debt-to-equity ratio of 0.89. The company has a 50-day moving average of $61.00 and a 200 day moving average of $60.35. Prestige Consumer Healthcare Inc. has a 12-month low of $48.51 and a 12-month high of $68.54. The stock has a market cap of $2.87 billion, a PE ratio of -33.85, a P/E/G ratio of 1.71 and a beta of 0.59.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.01 by $0.05. The firm had revenue of $279.31 million during the quarter, compared to analysts’ expectations of $278.79 million. Prestige Consumer Healthcare had a positive return on equity of 13.47% and a negative net margin of 7.46%. The business’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter last year, the firm earned $1.09 earnings per share. As a group, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.31 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Portside Wealth Group LLC acquired a new stake in Prestige Consumer Healthcare during the second quarter worth about $3,337,000. Comerica Bank purchased a new stake in shares of Prestige Consumer Healthcare in the 2nd quarter valued at approximately $3,905,000. Teachers Retirement System of The State of Kentucky increased its holdings in shares of Prestige Consumer Healthcare by 5.8% during the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 15,973 shares of the company’s stock worth $949,000 after buying an additional 874 shares during the last quarter. Woodline Partners LP purchased a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter valued at approximately $2,278,000. Finally, Captrust Financial Advisors raised its position in shares of Prestige Consumer Healthcare by 9.7% during the 2nd quarter. Captrust Financial Advisors now owns 4,963 shares of the company’s stock valued at $295,000 after buying an additional 437 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of research analyst reports. StockNews.com started coverage on shares of Prestige Consumer Healthcare in a research report on Thursday, August 17th. They set a “buy” rating for the company. TheStreet downgraded shares of Prestige Consumer Healthcare from a “b” rating to a “c+” rating in a research report on Thursday, September 7th. Finally, 3M reiterated a “reiterates” rating on shares of Prestige Consumer Healthcare in a report on Monday, June 26th. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $82.00.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.